Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Cognitive Impairment in Multiple Sclerosis].
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial.
Helicobacter pylori serology in autoimmune diseases - fact or fiction?
Acid-sensing ion channels in pathological conditions.
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells.
Oxidative stress and neurodegenerative disease.
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
Quantifying progression of multiple sclerosis via classification of depth videos.
The role of epidemiology in MS research: Past successes, current challenges and future potential.
Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images.
The prevalence of incidental findings in multiple sclerosis patients.
Multiple sclerosis in New Zealand.
Simvastatin Treatment of Patients With Acute Optic Neuritis
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Autonomic dysreflexia in acute disseminated encephalomyelitis.
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies.
Early onset optic neuritis following measles-rubella vaccination.
Patient Characteristics Associated with Medication Adherence.
Pages
« first
‹ previous
…
350
351
352
353
354
355
356
357
358
…
next ›
last »